1. Academic Validation
  2. Small Molecule Modulator of the mTORC2 Pathway Discovered from a DEL Library Designed to Bind to Pleckstrin Homology Domains

Small Molecule Modulator of the mTORC2 Pathway Discovered from a DEL Library Designed to Bind to Pleckstrin Homology Domains

  • ACS Chem Biol. 2024 Dec 20;19(12):2502-2514. doi: 10.1021/acschembio.4c00597.
Arthur Gonse 1 Jelena Gajić 1 2 Jean-Pierre Daguer 1 Sofia Barluenga 1 Robbie Loewith 2 Nicolas Winssinger 1
Affiliations

Affiliations

  • 1 Department of Organic Chemistry, Faculty of Sciences, University of Geneva, Geneva 12004, Switzerland.
  • 2 Department of Molecular and Cellular Biology, Faculty of Sciences, University of Geneva, Geneva 1204, Switzerland.
Abstract

Pleckstrin homology (PH) domains are structural motifs critical for cellular processes, such as signal transduction and cytoskeletal organization. Due to their involvement in various diseases, PH domains are promising therapeutic targets, yet their highly charged and hydrophobic binding sites are not ideal for traditional small drugs. In this study, we designed a DNA-encoded library (DEL) mimicking Phospholipids to identify novel modulators targeting PH domains with uncharted chemical properties. Screening against several PH domains led to the discovery of 2DII, a small molecule that selectively binds to mSin1PH. This compound can modulate mTORC2 activity by impairing mTORC2's membrane interactions, resulting in reduced Akt1 phosphorylation. A micromapping via Dexter energy transfer based on 2DII bearing an iridium catalyst (2DII-Ir), along with a biotin-diazirine small molecule was used for target identification by proteomics, which confirmed mSin1 as the primary intracellular target of 2DII, demonstrating its potential for selective mTORC2 pathway modulation. These findings introduce a novel strategy for targeting PH domains and provide a foundation for the development of therapeutic interventions that modulate PH-domain-dependent signaling pathways.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-169960
    mTORC2抑制剂